Supplemental Figure 1 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 1: T-cell immunological response to PSA over time: Panel A: IFNγ ELISPOT data, similar to that as shown in Figure 3, were plotted over time, subtracting the pre-treatment value, to evaluate the magnitude and durability of immunity over time. Panel B: Immune response over time was plotted as "area under the curve," and evaluated with respect to treatment arm. Lines show median and interquartile range.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362409710